Abstract P3-14-14: Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients

MLA

Kalliopi P. Siziopikou, et al. “Abstract P3-14-14: Neoadjuvant Phase II Trial with Carboplatin and Eribulin in Triple Negative Breast Cancer Patients.” Cancer Research, vol. 73, Dec. 2013, pp. P3-14. EBSCOhost, https://doi.org/10.1158/0008-5472.sabcs13-p3-14-14.

APA

Kalliopi P. Siziopikou, Jacqueline S. Jeruss, Sara Barnato Giordano, WL Gradishar, Steve Rosen, Kevin P. Bethke, Virginia G. Kaklamani, J H Von Roenn, Nora M. Hansen, Seema A. Khan, & Caitlin Meservey. (2013). Abstract P3-14-14: Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients. Cancer Research, 73, P3-14. https://doi.org/10.1158/0008-5472.sabcs13-p3-14-14

Chicago

Kalliopi P. Siziopikou, Jacqueline S. Jeruss, Sara Barnato Giordano, WL Gradishar, Steve Rosen, Kevin P. Bethke, Virginia G. Kaklamani, et al. 2013. “Abstract P3-14-14: Neoadjuvant Phase II Trial with Carboplatin and Eribulin in Triple Negative Breast Cancer Patients.” Cancer Research 73 (December): P3-14. doi:10.1158/0008-5472.sabcs13-p3-14-14.